febit holding gmbh
Random access genomic analysis solutions
febit was founded in Heidelberg, Germany. The first geniom® instruments were sold in 2003.
Cord F. Staehler (President, CEO)
Peer F. Staehler (VP, Marketing & Sales; CSO)
Jochen Kohlhaas (CFO)
febit biotech gmbh
Im Neuenheimer Feld 519
D-69120 Heidelberg
Germany
Phone: +49-6221-65176-00
Fax: +49-6221-65176-01
geniom® one, a fully integrated benchtop facility for microarray laboratory work for individualised microarrays, synthesis, hybridisation and analysis
Related patents
- Method for producing finished chemical surfaces
- Method for producing polymers
- Photoactivatable two-stage protective groups for the synthesis of biopolymers
- Microfluidic reaction carrier
- Incorporation of hapten groups during the production of carriers for the determination of analytes
- Method for the validated construction of arrays
- Microfluidic reaction carrier having three flow levels and a transparent protective layer
- Highly parallel template-based dna synthesizer
- Microfluidic component and analysis device
- Polymerase-independent analysis of the sequence of polynucleotides
- Method and device for the integrated synthesis and analysis of analytes on a support
- Biochemical analysis instrument uses mixture of sample and smart reagent beads viewed by color CCD camera to perform chemical analysis of medical samples
- Method for producing polymers
- Support for analyte determination methods and method for producing the support
- Substrate for methods to determine analytes and methods to manufacture such substrates
- Method for the quality control of functionalized surfaces
- Substrate for analyte determination and methods for manufacturing such substrates
- Preparation of spatially resolved substance libraries, preferably polymer libraries, comprises immobilizing chemical reactions and controlling photo-sensitive precursors of activating reagent in fluidic space
- Method for producing polymers
- Method for producing a fluid device, fluid device and analysis apparatus
- Method for selection of optimal microarray probes
Related news
- Blood-borne microRNA Signatures as Specific Biomarkers for Melanoma
- febit’s miRBase 14 Geniom-Biochip Now With 58 Additional New Sequences Available for Cancer Research
- Targeted resequencing of cancer-related genes with febit’s Cancer Exon Biochip
- febit Launches New Instrument for Targeted NextGen Sequencing with High Sample Throughput at AGBT Conference
- The Scientist Magazine Recognizes febit’s HybSelect Among the Winners of “Top 10 Innovations of 2009
- Life Technologies and febit Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies
- febit First to Offer Newly Published Mouse Genome on a Chip for DNA/RNA Detection and Enrichment
- febit offers cutting-edge tools for maturing miRNA research
- Automated Sequence Capture for Next-Generation Sequencing Paves the Way for Personalized Medicine
- febit Joins the READNA Consortium With its Novel Sequence Capture Technology
- febit Announces Strategic Investment and Technology Development Agreement with In-Q-Tel
- febit-WEBINAR: The Human Genome as an RNA Machine
- febit Receives US Patent for Microfluidic Extraction Method
- febit First to Offer miRBase 11.0 Biochip
- febit Files Patent Infringement Lawsuit Against Codon Devices
- Anthony Caruso Joins febit Team
- febit Launches Analyzer for Geniom Ready-to-Go Biochips
- febit Launches Analyzer for Geniom Ready-to-Go Biochips
- New from febit: The Huge world of microRNAs on one Chip